Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number, PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS.
Introduction
One of the hallmarks of cancer cells is a decrease in or resistance to cell death coupled with an increase in cell proliferation. In particular, cancer cells can resist conventional chemotherapeutic agents by evading apoptosis. Therefore, a mechanistic understanding of the processes that link cell proliferation and cell death will provide important knowledge in the treatment of cancer. Cell death by apoptosis plays an essential role in normal development and physiology in the breast (Jacobson et al., 1997) as well as in the development of breast Cancer (Schedin et al., 1996; Wu, 1996) . The degree of apoptosis can be an important factor in both the progression of breast cancer and the response to treatment (Furth, 1999; Lipponen, 1999) . A high apoptotic index (number of apoptotic cells per square millimeter of neoplastic tissue) is related to malignant cellular features and is an indicator of invasiveness and cell proliferation in breast cancer (Lipponen, 1999) . The response to treatment of breast cancer is improved by increasing the percentage of cells undergoing apoptosis. Thus, cell cycle progression and control of apoptosis are thought to be intimately linked processes. Mitosis and apoptosis are closely interrelated (Lipponen et al., 1994) . Although proteins that regulate apoptosis have been implicated in restraining cell cycle entry (Hauf et al., 2001 ) and controlling ploidy (Minn et al., 1996) , the effector molecules at the interface between cell proliferation and cell survival have remained elusive. The purpose of the study is to identify the effector molecules that act as a link between cell proliferation, cell survival and chromosomal stability. We have hypothesized that chromosomal segregation and apoptotic pathways are linked and have a role in the development of aneuploidy in breast tumors. Human Rad2l, a protein that establishes and maintains sister chromatid cohesion during mitosis, may provide a link between cell division and cell death: and cleavage of Rad2l may signal subsequent events of cell death including DNA degradation. We also hypothesize that hRad2l helps maintain chromosomal stability in mammary cells and its dysregulation results in breast cancer formation. To test these hypotheses we have the following specific aims: 1) evaluate the role ofhRad21 in the apoptotic response and the role of apoptotic proteins on cleavage of hRad2l; and 2) determine the expression and localization of hRad2l protein and mRNA in normal and malignant breast carcinoma cell lines and tumor specimens with known levels of aneuploidy.
Following is the final report for this project that includes a no cost extension for the period of July 1, 2004-June . We have completed the first technical objective (role of Rad21, in apoptotic response) and have made substantial progress in the second objective (Rad21 expression in breast tumors). Over the last year, with limited resources we just focused on the characterization of the protease that cleaves Rad2l during apoptotic response. Our other focus was to prepare and submit grant proposals to seek funding to continue this line of research. We have been successful in both of these goals. Our research indicates the presence of a novel Rad21 protease in the nucleus, which remains to be identified. Recently I have secured funding from NIH to carry out the identification and characterization of this novel Rad2l protease.
In summary, the research carried out as the part of this CDA award indicates that in addition to establishing and maintaining sister chromatid cohesion during mitosis, hRad21 plays a direct role in apoptosis, and its cleavage during apoptosis by a novel protease act as a nuclear signal to initiate cytoplasmic events involved in the apoptotic pathway. A manuscript describing this work (see Appendix III) was published in the Journal of Molecular and Cellular Biology , one manuscript is under revision and two more manuscripts are in preparation. In accordance with the approved statement of work, tasks for technical objective 1 and 2 have been completed (Appendix I).
Body of the report
Rad2l is one of the major cohesin subunits that holds sister chromatids together until anaphase, when proteolytic cleavage by separase, a caspase-like enzyme, allows chromosomal separation (Uhlmann et al., 1999;  Biggins and Murray, 1999, Hauf et al., 2001 ). Rad2l plays a critical role in the eukaryotic cell division cycle by regulating sister chromatid cohesion and separation at the metaphase to anaphase transition (Ciosk et al., 1998; Michaelis et al., 1997; . However, in addition to its role in chromosomal segregation, cohesins can associate with different sets of proteins to achieve diverse functions, including regulation of gene expression, DNA repair, cell cycle checkpoints and centromere organization (for a review see Hagstrom and Meyer, 2003) . Surprisingly, work from ours and others have indicated that not only cohesin Rad2l plays a critical role in mitosis, it can also induce apoptosis , Chen et al., 2002 .
Little is known about the role of Rad2l in human malignancies. We have characterized the role of Rad2l in .
FLAG-C-Term
Rad2l like that of the 64-kDa Rad21, the 60-kDa Rad2l C-terminal -. phenotype of the DAPI-stained nuclei. Cells transfected with hRad21 C-terminal plasmids had considerably higher concentrations of cellular and nuclear phenotypes typical of apoptosis, such as having a round appearance with shrunken cell volume, chromatin condensation, and nuclear disintegration, than did cells with intact hRad21WT constructs.
Results indicate the proapoptotic activity of the C-terminal Rad2l fragments appears to rely on the endogenous status of Rad2l protein (Fig. 2) . For example, when overexpressed, both the C-terminal fragments of Rad2l (60 kDa [Fig. 2, panel 2] and 64 kDa, [data not shown]) induce apoptosis in tumor cells with higher endogenous Rad2l levels (e.g., myeloid leukemia cells Molt4, ML-1, and HL60), while primary lymphocytes and tumor cells with low Rad2l expression (e.g. KG IA cells) are resistant, thus making Rad2l protein status an ideal target for therapy. This phenomenon may be due to:
(a) a hyperactive export mechanism that regulates the translocation of the pro-apoptotic Rad2l C-terminal fragment to the cytoplasm in Rad2l overexpressed cells or (b) an overactive Rad21-specific protease in cells with a high level of Rad2l, resulting in higher Rad2l cleavage and translocation to cytoplasm.
We have further examined the importance of the proteolytic cleavage of Rad2l during apoptosis by engineering a Rad21 construct in which the endogenous apoptotic cleavage site is replaced by the TEV protease recognition sequence (TEV-Rad21). Expression of TEV-Rad21 alone had no effect on the cell cycle, where as coexpression of TEV-Rad21 with the highly specific TEV protease induced apoptosis in Jurkat and 293 cells (Fig. 3) . In this assay, inclusion of TEV recognition site to other parts of Rad2l had no effect (data not shown). Thus, Pati , Debananda, Ph.D. Feasibility of the purification scheme to identify the protease that cleaves Rad2l. To identify the physiological protease that cleaves Rad21 in the nucleus early in apoptosis, we undertook a set of pilot studies using Mono Q, an anion-exchange column, to isolate the enzymatically active fractions based on surface charge of the molecule, along with a BioLogic DuoFlow chromatography system (Bio-Rad, Hercules, CA). A Mono Q column contains quaternary amine groups and thus has a positive charge. • on a Mono 0 column: (A) Assay for caspases 3 and 7 contamination of the nuclear fraction used for FPLC 6 2.5 2. Molt4 cells were treated with 10 !tM etoposide for 2.5 h. Quantitative measurement of early apoptosis was performed by staining a sample of cells following etoposide treatment with Annexin V as previously described . Isolation of nuclei was based on osmotic shock followed by sucrose gradient centrifugation. The quality and density of the nuclei were monitored by staining of the nuclear material with DAPI and visualization using a hemocytometer. Our lab uses this method routinely to prepare nuclei from Molt4 cells with high purity . The purity of the nuclear fraction was verified in a Western blot using nuclear lamin and cytoplasmic tubulin antibodies and was found to be pure with no detectable cytoplasmic contamination . Although Western blot analysis was used to identify contamination of the nuclear preparations with cytoplasmic caspase 3 and caspase 7, two major apoptotic proteases, contamination was not detected (Fig. 5A ). Fast-performance liquid chromatography (FPLC) was used to purify nuclear lysates from early apoptotic Molt4 cells. Nuclear protein (500 mg at 1000 mg/ml) in buffer consisting of 10 mM Tris-HCL, 0.1 mM EDTA, I mM DTT (pH, 7.5), and 0.2 mM PMSF (buffer A) was applied to the Mono Q column, which had been equilibrated and developed with the same buffer. Then 0.75-ml fractions were collected and the enzymatic activity was tested in an in vitro 35 S-Rad21 cleavage assay as described previously . As shown in Fig. 5B , in vitro translated Rad2l was cleaved by the Molt4 nuclear lysates that were treated for 2.5 h with 10 IuM etoposide (lane 2). However, control lysates treated solely with vehicle failed to cleave Rad21 in the cleavage assay (lane 1). FPLC fractions 14-19 were able to cleave Rad2l in the in vitro cleavage assay indicating the presence of active enzyme fractions, and the intensity of the cleavage bands' peak in fractions 16 and 17. We confirmed these findings using fractions 13-20 to cleave Rad2lemploying in vitro translated unlabelled hRad21 in wheat germ extracts and assaying the cleavage in Rad21 immunoblots (Fig. 5C ). The broad-spectrum caspase inhibitor z-VAD-FMK, but not the control peptide z-FA-FMK, could inhibit the cleavage of the 64-kDa hRad21 fragment by FPLC fraction 16 at higher doses (1 mM), but it had no effect on the 60-kDa fragment (Fig. 5D ). Because these findings suggest the involvement of a novel caspase-like protease, they support the hypothesis that a nuclear protease cleaves Rad2l early in apoptosis and can be isolated.
In future the identification and characterization of this novel protease should be carried out. Identification of this protease not only will shed light on the nuclear signal that initiates apoptosis, will also provide a ideal target for therapeutic intervention. These experiments were instrumental in identifying if Rad2l cleavage is essential for induction of apoptosis and/or sensitizes cells to undergo apoptosis after exposure to apoptotic agents.
Sequence mining indicates that a region of 104 amino acid residues in C-terminal Rad2l has high consensus (26% identities, 43% positives) with the sequence upstream of the death domain (DD) of several apoptosis related proteins (Fig. 6 ), such as Tumor Necrosis Factor (TNF) receptor super family, apoptosis inducing receptor TRAIL-R2, and apoptosis inducing protein/death receptor 5 (Schneider et al 1997, Screaton et al 1997, Sheridan et al 1997, Walczak et al 1997). However, the functional significance of this domain in apoptosis-inducing proteins is not known. TNF receptor superfamily members have DD and their involvement in apoptosis requires TNF signaling from outside of the cell. C-terminal Rad2l does not have a death domain. It is currently not known whether Cterminal Rad2l induced apoptosis requires extracellular signals, like those in the TNF superfamily. The conserve sequence between C-terminal Rad2l and TNF receptor superfamily members implies that Apoptosis induced by C-terminal Rad2l and the tumor necrosis factor (TNF) receptor superfamily may share part of the common apoptotic pathway. Fig.6 Homology of C-terminal human Rad2l (amino acids 257-360) with apoptosis-inducing proteins (AIP) that include tumor necrosis factor receptor superfamily (member 10b, amino acids 188-286), apoptosis inducing receptor TRAIL-R2 (amino acids 263-361), and apoptosis inducing protein/death receptor 5 (amino acids 234-332). All these apoptosis-inducing proteins have a region with the same amino acid sequence.
To characterize the role of this identified AlP domain in C-terminal Rad2l, we have set up a Hela Tet-On gene expression systems conditionally expressing Rad2l full length, Rad2l(1-282aa), Rad2l(281-631 aa) and Rad2l(253-631 aa). Gene expression in Tet-on system is turned on by adding doxycycline and is tightly regulated in response to varying concentrations of doxycycline. These inducible cell lines are important reagent to study the Cterminal Rad2l stimulated apoptosis. We have also generated similar systems for the MCF7 breast cancer cell line, which will be used in testing C-terminal Rad2 1-induced apoptosis in breast cancer cells and will provide a valuable tool to probe the apoptotic activity of Rad2l.
Pati, Debananda, Ph.D.
Aim 2) Expression and localization of Rad2l Protein and mRNA in normal and malignant breast carcinoma cell lines and tumor samples: We have examined the expression pattern of Rad2l message and protein in a variety of breast cancer cell lines (MCF7, MDA-MB-157, MDA-MB-231, MDA-MB-436, BT-20, HBLIOO, and SKBR-3 . In these cells, Rad2l appeared to have altered expression patterns. Compared to normal human mammary epithelial cells (H-MEC), Rad21 mRNA is overexpressed in all the cells tested, except for BT20, where its expression was found to be considerably down regulated. However, subsequent Southern blot analysis of the genomic DNA from the breast cancer cell lines didn't reveal any defects in Rad21 gene structure. Expression and localization of the hRad21 protein in normal and malignant breast cancer cells were performed using immunocytochemistry and immunofluorescence techniques. hRad21 efficiently localizes to the nucleus of various mammalian cells assayed by immunofluorescence staining using either the affinity purified polyclonal or monoclonal hRad21 antibodies, developed by us. specimen. The signal was developed using 3,3'-diaminobenzidine chrmogen (brown) with a methyl green counter stain. In the center shows normal tissue (arrow). X 100 maginification.
To further characterize the contribution of Rad2l to tumor localization of Rad2l protein, we used immunohistochemistry (Allred et al., 1993; Berardo et al., 1998) in 800 human breast tumor specimens with known status for aneuploidy, estrogen receptor, and a number of other markers with appropriate controls available from the Allred lab at the Baylor Breast Cancer Center. The Allred lab has assisted us in developing a robust assay to immunolocalize the hRad21 protein using monoclonal hRad21 antibody. Since most referral specimens are fixed 10% neutral buffered formalin and processed at variable rates and times, increased sensitivity and standardization of the assay is achieved through the use of heat induced antigen retrieval post-deparaffinization. Endogenous nonspecific protein blocking then follows. Subsequently, incubation with the primary antibody (monoclonal hRad2 1) is performed, followed by a biotinylated secondary antibody incubation directed against the mouse. These are then followed by incubation in horseradish peroxidase (HRP)-labeled streptavidin, which then binds to the biotin label of the secondary antibody. The entire reaction is then visualized by incubation with 3,3 diaminobenzedine which, in the presence of HRP, produces a brown reaction product at the site of the antigen-antibody interaction. Enhancement of the reaction product is achieved by the addition of the heavy metal osmium tetroxide, which increases the tone of the reaction product and elevates the signal: noise ratio of the assay. Scoring of immunostained slides for hRad21 expression is preformed by the PI in a blinded way according to the protocol described for Bcl-2 expression in breast tumor specimens (Berardo et al., 1998) and based on the proportion of cells staining positive, described by the Allred laboratory. Statistical analysis of these samples have been completed by the statistics core (S.G. Hilsenbeck and C.C. Chenault) of the Breast Center at Baylor College of Medicine. Analysis indicates aberrant expression of Rad2l in human breast tumors. For an example, in one set of tumors Rad2l is highly overexpressed while in another set its expression is completely absent. There appears to be a high correlation between Rad2l expression in tumor and adjacent cells. Typically, Rad2l find to be expressed higher in infiltrating breast cancer (IBC) than in normal. The p value (P<0.001) indicated a highly significant difference. No obvious association was noted between ploidy of tumor and Rad2l expression in tumor tissues. However, it appears that there is an association between tumor ploidy and the expression of Rad2l in adjacent normal tissues that is statistically significant. There is a modest association between Rad2l and ER positivity in IBC but not in normal tissue. There was no significant association between Rad2l expression with cathepsin-D, her2-neu and EGFR. Due to lack of availability of enough sample materials, we were not able to perform the TUNEL assay as proposed to correlate the apoptotic index with Rad2l expression in these specimens. Based on these results, in future studies Rad21 can be evaluated as a potential candidate prognostic marker for breast cancer progression.
Due to difficulty in isolating RNA from frozen tumor specimens, expressions of hRAD21 mRNA was being investigated in a subset of 10 breast tumors with Northern blot analysis. However, due to poor quality of the RNA, Northern analysis of Rad2l expression was not successful. The LOH studies (technical objective 2B) were proposed in collaboration with Dr. Peter O'Connell. This collaboration could not materialized partly due to the relocation of the O'Connell lab and partly due to lack of samples. Hence, this sub-aim was not pursued.
As described above, studies in over 800 human breast tumor specimen indicate that Rad21 is significantly overexpressed in human breast cancer cells in comparison to normal cells (Fig. 7 , Zhang, AlIred and Pati, manuscript in preparation), making it an attractive candidate for the adoptive immunotherapy with antigen-specific cytotoxic Tlymphocytes (CTL). Rad21 has also been reported to be amplified in prostrate cancer (Porkka et al., 2004) . Rad2l is a potential tumor-associated self antigen similar to survivin, telomerase and MDM2 (Gordan et al., 2002) . CTL specific for survivin and telomerase have been generated by several groups indicating that CTL can be successfully generated against self-antigens. Moreover, studies with survivin-specific CTL have shown that only tumor cells overexpressing survivin are recognized by CTL in contrast to non-malignant cells, likehematopoietic stem cells that express survivin at low levels (Pisarev et al., 2003) . Thus, we hypothesize that Rad21-specific CTL will only recognize Rad2l overexpressing malignant cells. Sofar the immune response to Rad2l has not been studied and we have recently secured seed funds from the Baylor Cancer Center to generate Rad2 1-specific CTL for the adoptive immunotherapy of Rad2l positive breast cancer.
Mechanism of Hormone induced Aneuploidy: Over the last year I have embarked upon a new project to study the mechanism of steroid hormone induced aneuploidy in p53 null mammary epithelium. The absence of p53 function increases risk for spontaneous tumorigenesis in the mammary gland. Hormonal (estrogen and progesterone) stimulation enhances tumor risk in p53-null mammary epithelial cells as well as the incidence of aneuploidy. Aneuploidy appears in normal p53-null mammary epithelial cells within 5 weeks of hormone stimulation. In collaboration with Dr. Daniel Medina's laboratory at Baylor College of Medicine we investigated a possible mechanism of hormone-induced aneuploidy. Hormones increased DNA synthesis equally between wild-type (WT) and p53-null mammary epithelial cells. There were two distinct responses in p53-null cells to hormone exposure. First, Western blot analysis demonstrated that the levels of two proteins involved in regulating sister chromatid separation and the spindle checkpoint, Mad2 and separase (ESPLI) were increased in null compared with WT cells. In contrast, the levels of securin and Rad2l proteins were not increased in hormone-stimulated p53-null compared with WT cells. ESPLI RNA was also increased in p53-null mouse mammary cells in vivo by 18 h of hormone stimulation and in human breast MCF7 cells in monolayer culture by 8 h of hormone stimulation. Furthermore, both promoters contained p53 and steroid hormone response elements. Mad2 protein was increased as a consequence of the absence of p53 function. The increase in Mad2 protein was observed also at the cellular level by immunohistochemistry. Second, hormones increased gene amplification in the distal arm of chromosome 2, as shown by comparative genomic hybridization. These results support the hypothesis that hormone stimulation acts to increase aneuploidy by several mechanisms. First, by increasing mitogenesis in the absence of the p53 checkpoint in G2, hormones allow the accumulation of cells that have experienced chromosome missegregation. Second, the absolute rate of chromosome missegregation may be increased by alterations in the levels of two proteins, separase and Mad2, which are important for maintaining chromosomal segregation and the normal spindle checkpoint during mitosis. This work was published in Cancer Research . Recently, I have also secured funding from Susan G. Komen Foundation and from NIH in the form of a RO I grant to study further the molecular basis of aneuploidy in breast cancer.
Key Research Accomplishments "* Human Rad2l (hRad2l) cohesin is cleaved at residue Asp (D) 27 9 and Cys-392 (C 3 9 2 ) by a novel Caspase-like protease in the nucleus early in apoptotic process. The cleaved carboxy-terminal products are translocated to the cytoplasm early in apoptosis before chromatin condensation and nuclear fragmentation. "* Cleavage of Rad2l close to its endogenous, apoptotic cleavage site is sufficient to induce apoptosis in both apoptosis sensitive and resistant cells providing a direct and novel role of Rad2l in apoptosis. "* Overexpression of the 60 and 64 kDa cleavage product results in apoptosis in MCF-7 breast cancer cells.
Given the role of hRad2l in chromosome cohesion, the cleaved C-terminal product and its translocation to the cytoplasm may act as a nuclear signal for apoptosis. "* Studies show that Rad2l can be cleaved in Caspase-3 deficient MCF7 cells in which Caspase-7 activity is blocked by siRNA/antibody treatment suggest that Caspase-3 and -7 are not the essential proteases that cleave Rad2 1. Since Rad21 is a nuclear protein and the cleavage initially occurs in the nucleus, the protease that cleaves Rad2l may reside inside the nucleus. Caspase-2 is localized in nucleus, but it cannot cleave Rad21 in vitro. These findings suggest the presence of a novel Caspase or Caspase-like molecule in the nucleus that cleaves Rad21 early in apoptosis. 
Conclusion
In summary, in contrast to previously described functions of Rad21, in chromosome segregation and DNA repair, cleavage of the cohesion protein and translocation of the C-terminal cleavage products to the cytoplasm are early events in the apoptotic pathway that amplify the apoptotic signal in a positive feed back manner by activating more Caspases. It is apparent that cohesin Rad2l may act as an interface between cohesion and cell death, and its cleavage may signal subsequent events of apoptosis. These results provide the framework for establishing a link between sister chromatid cohesion and the apoptotic response that have not previously been tested in any model system. Furthermore, our studies indicate overexpression of Rad2l protein in human breast tumor specimens. Future studies will identify the physiological protease that cleaves Rad21 and role of hRad21 in the apoptotic response in normal and malignant cells. Will not be carried out. A study published recently from another lab has performed similar experiments proposed in this objective. In this study by Chen et al. (2002) have examined the role of survivin on Rad21-induced apoptosis. These studies indicated that Rad21-induced apoptosis can be inhibited by anti-apoptotic proteins such as Survivin. Rad21 is one of the major cohesin subunits that holds sister chromatids together until anaphase, when proteolytic cleavage by separase, a caspase-like enzyme, allows chromosomal separation. We show that cleavage of human Rad2l (hRad2l) also occurs during apoptosis induced by diverse stimuli. Induction of apoptosis in multiple human cell lines results in the early (4 h after insult) generation of 64-and 60-kDa carboxyterminal hRad21 cleavage products. We biochemically mapped an apoptotic cleavage site at residue Asp-279 (D 279 ) of hRad2l. This apoptotic cleavage site is distinct from previously described mitotic cleavage sites. hRad21 is a nuclear protein; however, the cleaved 64-kDa carboxy-terminal product is translocated to the cytoplasm early in apoptosis before chromatin condensation and nuclear fragmentation. Overexpression of the 64-kI)a cleavage product results in apoptosis in Molt4, MCF-7, and 293T cells, as determined by TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling) and Annexin V staining, assaying of caspase-3 activity, and examination of nuclear morphology. Given the role of hRad21 in chromosome cohesion, the cleaved C-terminal product and its translocation to the cytoplasm may act as a nuclear signal for apoptosis. In summary, we show that cleavage of a cohesion protein and translocation of the C-terminal cleavage product to the cytoplasm are early events in the apoptotic pathway and cause amplification of the cell death signal in a positive-feedback manner.
Normal development and homeostasis require the orderly chromatids (28, 30) . Cleavage depends on a CD clan endopepregulation of both cell proliferation and cell survival. Cell cycle tidase, Espl (also known as separin/separase) (37, 38) , which is progression and control of apoptosis are thought to be inticomplexed with its inhibitor, Pdsl (securin), before anaphase mately linked processes. Activation of the cell cycle plays a (23, 39) . In metaphase, ubiquitin-mediated degradation of the significant role in the regulation of apoptosis (16); in some cell securin protein by APC/C-Cdc20 ubiquitin-ligase releases setypes and under certain conditions, apoptosis has been shown parin protein, which proteolytically cleaves cohesin Rad2l, to occur only at specific stages of the cell cycle (24) . Mitosis thereby releasing the sister chromatids (6, 7, 10, 18, 42) . In and apoptosis are also closely interrelated (25) , and the mitotic budding yeast, fission yeast, and human cells, Rad2l has two index is the most important determinant of the apoptotic index mitotic cleavage sites for separase (12, 37, 38) , and cleavage by (25) . Although proteins that regulate apoptosis have been imseparase appears to be essential for sister chromatid separaplicated in the restraint of cell cycle entry (14) and the control tion and for the completion of cytokinesis (12) . In contrast to of ploidy (29), the effector molecules at the interface between the simultaneous release of cohesin from the chromosome cell proliferation and cell survival have remained elusive, arms and centromere region in budding yeast by separase Studies with yeast and higher eukaryotes, including humans, cleavage, most cohesin in metazoans is removed in early have indicated that an evolutionarily conserved protein comprophase from chromosome arms by a cleavage-independent plex, called cohesin, and its subunit, Mcdl/Sccl/hRad21, are mechanism (12, 39, 40) . Only residual amounts of cohesin are required for appropriate arrangement of chromosomes during cleaved at the onset of anaphase, coinciding with its disappearnormal cell division (11, 28 ; for a review, see references 20, 30, ance from centromeres. Thus, Sccl!Mcdl/Rad2l plays a criti-31, and 36). Analyses of Rad2l function in fission yeast, Schizocal role in the eukaryotic cell division cycle by regulating sister saccharomyces pombe, and of Sccl/Mcdl function in budding chromatid cohesion and separation at the metaphase-to-anyeast, Saccharomyces cerevisiae, have demonstrated that the aphase transition. nuclear phosphoprotein is required for appropriate chromoOur results indicate that in addition to establishing and somal cohesion during the mitotic cell cycle and double-strandmaintaining sister chromatid cohesion during mitosis, hRad21 break repair after DNA damage (1, 30) . Biochemical analysis plays a role in apoptosis, and its cleavage during apoptosis may of cohesin indicates that it acts as a molecular glue, and human act as a nuclear signal to initiate cytoplasmic events involved in cohesin can promote intermolecular DNA catenation, a mechthe apoptotic pathway. anism that links two sister chromatids together (26) . In budding yeast, loss of cohesion at the metaphase-anaphase transition is accompanied by proteolytic cleavage of the Scct/McdI MATERIALS AND METHODS were generated using a PCR-based site-directed mua 21-gauge needle. When appropriate, additional phosphatase inhibitor cocktails tagenesis protocol as previously described (33) . The PCR resulted in a 550-bp I and II (Sigma) were added to the lysis buffer at a dilution of 1:100. Lysates were internal hRAD21 fragment containing the mutations. A 221-bp piece of will-type then centrifuged at 1,000 X g for 20 min, and the supernatants were aliquoted (WT) bRAD21 (frori the Bsgl to PFLFI sites) was replaced with the comparable and frozen at -80'C until use. Protein samples were also made from the cytomutated fragment. The resulting plasmids, pCS2MT-hJiAD21-ACS-mut-1 and plasmie and nuclear fractions of apoptosis-induced Molt4 cells by using protocols pCS2MT-hRIJD21-ACS-mut-Il, were verified by DNA sequencing. The aminopreviously described (5) . The purities of the cytosolic and nuclear fractions were terminal (N-hRad2l, encoding amino acids [aa] I to 279) and carboxy-terminal verified by Western blotting with antibodies to tubulin and nuclear lamin, re-(C-hRad2l, encoding aa 280 to 631) cleavage products were cloned into myc spectively. After protein quantification (using detergent-compatible protein dye epitope-tagged pCS2MT vectors by using PCR amplification of the fragments and bovine serum albumin from Bio-Rad as standards) and normalization, 10 to from the h!?1lD21 eDNA. These constructs were also verified by DNA sequenc-40 ig of protein extracts was electrophoresed on SDS-polyacrylamide gel elecing.
trophoresis (PAGE) gels and transferred to polyvinylidene difluorile (PVDF) Generation of hRad21 pAb and mAb. Rabbit polyclonal antibody (pAb) wias membranes (Millipore, Bedford, Mass.). The filters were initially blocked with raised commercially (Covance. Denver, Pa.) against synthetic peptides corre-5% nonfat dry milk in Tris-bnffered saline containing 0.1% Tween 20 for I to 2 I1 sponding to the sequence of the 14 carboxy terminal aa of hRad21 (SDIIATat room temperature and then probed with hRad21 mAlb or hRad2l pAb at a PGPRF1Ill). Immunization and alfinity purification of antibodies were per-1:1.001 dilution, 1.5 Rg of oyr epitope/mI. 2.5 lig of Flag epitope/mI, P-actin at formed according to the manufactnrer's protocol. Monoclonal antibody (miAb) a 1:100,000 dilution, or PARP antiserum at a 1:2,000 dilution. The bound antiagainst a partial recombinant hRad21 protein (aa 240 to 631) was also raised bodies were visualized by the enhanced chemiluminescence detection system commercially (lmgenex, San tDiego, Calif.). Both antibodies had very high titers, (Amersham. Buckinghamshire, England), in combination with the horseradish as determined by enzyme-linked immunosorbenit assay. Both antibodies recogperoxidase-conjugated anti-mouse or anti-rabbit secondary antibodies as appronized the WT hRad21 protein as a specific 122-kDa band in Western blot priate. and the intensity of the specific bands in the exposed films was quantified. analysis and effectively immunoprecipitated endogenous hRad21 from various
In some of the later experiments, bound primary antibodies were detected with human and rodent cell lines and tissue lysates. linirimodetecrtion of the 122-kt~a IRD800 dye-labeled, appropriate species-specific secondary antisera and the band was blocked competitively by pretreatment of the lysates with recombinant signal was visualized on a Li-Cor (Lincoln, Nebr.) Odyssey infrared scanner.
hRad21 protein or synthetic C-terminal peptides. Both antibodies were also Immunoprecipitation (IP) was performed as follows. A 1.-mil sample of cell effective in inmiunohistochemnistry and immunofluorescence staining of both lysate was precleared by incubation with 10 p.Il of normal mouse immunoglobulin paraffin-embedded and tissue culture slides. G (lgG) and 201 pI of protein G plus agarose (Oncogene Research Products) at Antisera. Tile monoclonal antisera were obtained as follows: human poly-4C for I h on a rotator. The precleared lysate was collected after centrifugation (Anribsera.)The mpioclye ias (AniRa) wereom haringed, as f gov hmanf pFly at 800 ) g for 15 min. A 0.5-to 1.0-ml sample of precleaared lysate normalized for (ADP-ribose) polymerase (PARP) fromt PharMingen, San Diego, Calif.; Flag rti ocnrtoswsicbtdat4CfrIInihpiayatbde cpitope and mouse Il-uctin from Sigma, St. L~ouis, Mro.; c-niyc epitope (9El0), protein concentrations was incubated at 4°C for 1 hi with primaiy antibodies berialto e, andpmouse -3 frome-tSuigma, at. Lonisn fom: O-nicogne REsearch followed by the addition of 20 pA of protein A and protein G plus agarose. The bacterial trPE, caspase-3, caspase-7, tubulin, and lamin from Oncogenec Research mix was then incubated at 4a C for another 12 to 16 h on a rotator. Precipitates Products, Cambridge, Mass. hRad21 N-terminal antibody was a gift from J.-M.
were then washed four times with 1 ml of ice-cold PBS, with a final wash in the Peters (Research Institute of Molecular Pathology, Vienna, Austria).
lysis buffer before electrophoresis and Western blot analysis.
Cell cultures and transfection. MCF-7 breast carcinoma cells, human chorioMapping of lRad2l apoptotic cleavage sites. Apoptosis was induced in Molt4 carcinoma EG3 cells, and IMR90 priiiiary lung fibroblast cells were obtained T cells by treatment with 10 jiM etoposide for 8 Ih. Protein lysates were subjected from the Anierican Type Culture Collection (ATCC) and were maintained per to IP using hiRad21 mAb or a control bacterial opE mAb. 1 he immunoprecipi-ATCC protocol. Human Molt4 and Jurkat T-cell leukemia cells (both obtained tated samples were run on SDS-"i% PAGE gels that included (1.1 mM sodium from ATCC) were grown in RPMt 1640 mediuim Supplemented with 10%, fetal thioglycolate (Sigma) as a scavenger in the sipper running buffer. Electrophobovine serum and maintained at 37C, 95%, humidity, and an atiiosphere of 5% resed samples were then electroblotted onto PVDF membranes at 400 mA for 45 CO 2 . EL-12 mouse mammary epithelial cells were obtained from the Medina min at roomn temperature (--.25°C) using CAPS [3-(cyclohexylainino) propaneLaboratory (Baylor College of Medicine) and maintained as previously described sulfonic acid] buffer (10 mM CAPS, 10% methanol, pH 11). At the end of the (27) . Cells were transfected with appropriate plasmids in 100-mm-diameter transfer, the blotted membranes were rinsed with water for 2 to 5 min, stained dishes using Superfect or Effectene reagents from Qiagen (Valencia, Calif.) with 0.05% Coomassie blue in 1% acetic acid-50% methanol for 5 to 7 min, according to the manufacturer's protocol. A fixed amount of plasmid DNA was destained in 50% methanol until the background was pale blue (5 to 15 mrin), and used in any given experiment. The total amount of expression vector DNA was finally rinsed with water for 5 to 10 min. Appropriate bands were cut out and air equalized by the addition of blank vectors to control for proiioter competition dried and sent to the protein chemistry core laboratory at Baylor College of effects. When necessary, transfection efficiency was monitored by use of 1 ig of Medicine for N-terminal sequencing. . Fresh medium was added immediately after UV Drug treatments. Etoposide (VP-16) (20-mg/mi injections) and camptothecin radiation. Cells were fixed with cold methanol after 6 h of UV treatment unless were purchased from GensiaSicor Pharmaceuticals (Irvine, Calif.) and Sigma, otherwise noted. Double staining of hRad21 was performed by incubating antirespectively. Camptothecin was dissolved in dimethyl sulfoxide (DMSO) and hRad21 mAb and rabbit anti-C-terminal-hRad2l pAb. The signals of mAb and stored in aliquots at -20'C. Cells were plated at a concentration of 6 x 106 pAb were visualized by the addition of rhodamine-labeled goat anti-mouse lgG cells/ml and treated with appropriate concentrations of drugs. Moht4 cells were (1:100) and fluorescein-labeled goat anti-rabbit IgG (1:800) (Molecular Probes), treated with etoposide, while Jurkat cells were treated with camptothecin for 8 h respectively. Slides were mounted with Vectashield mounting medium with unless otherwise indicated. Controls were treated with equivalent dosages of DAPI (4',6'-diamidino-2-phenylindole; H-1200, Vector) and sealed with nail vehicle. The caspase inhibitor z-VAD-FMK was also dissolved in DMSO and makeup. Images were obtained with a Zeiss inverted fluorescence microscope stored at -20'C. Peptide aldehydes MGl5 and MG132 were obtained from coupled to an Axiocam high-resolution digital camera operated with Axiovision Peptide Institute, Inc. (Lexington, Ky.) and dissolved at a concentration of 10 3.0 software (Carl Zeiss Inc., Thornwood, N.Y.). mM in DMSO. Cells were treated with a 0.025 mM concentration of proteasome For detection of apoptosis in transiently transfected 293T and MCF-7 cells, 1 inhibitors for 8 h before harvesting. 15-Deoxy-delta(12,14)-prostaglandin J 2 million cells were seeded onto 100-mm-diameter culture dishes 2 days prior to (1SdPGJ,) was purchased from Cayman Chemical Co. (Ann Arbor, Mich.).
transfection. Cells were transfected with the indicated hRad21 constructs when Induction of apoptosis in JEG3 cells by using 15dPGJ, was carried out as they reached 60% confluence. For DAPI staining, cells were cotransfected with previously described (19 PAGE (4 to 20% acrylamide) gel, transferred to a nitrocellulose meeand propidiutm iodide (P1) was used to distinguish between cells undergoing braGe, and analyzed by Western blot using a monoclonal hRad21 apoptosis (PI negative) and those that were necrotic or dead (PI positive).
antibody. Induction of apoptosis resulted in the generation of approxApoptotic cells were identified with TUNEL staining using fluorescein-dUTP as imately 64-and 60-kDa hRad21 cleavage products (shown by the the substrate, closed arrows). Full-length hRad2l (122 kDa) is indicated by the open The caspase-3 activities in Molt4 cells were measured using a caspase-3 assay arrow. kit from Clontech according to the manufacturer's protocol.
Proteulytic cleavage assay of the in vitro transcribed and translated hRad2M.
15S-hRad21 or unlabeled (nonisotopic) hRad21 was produced by in vitro transcription-translation using the TNT rabbit reticulocyte lysate system (Promega. also detected in a number of other cell lines following induc- "with various hRad21 constructs were measured using a paired test of proportions nuclear fractions by using a C-terminal hRad21 antibody debased on binomials (8). The results of the caspase-3 activity assay were analyzed tected a 122-kDa protein band in the noninduced cells (0 h), using Student's t test. and as reported before (12), full-length hRad21 was found exclusively in the nuclear fractions (Fig. 2B) . However, induc-RESULTS tion of apoptosis resulted in the early (4 h after induction) generation of approximately 64-and 60-kDa cleavage prodWe report the role of hRad2l in the apoptotic response and ucts, as determined by a C-terminal hRad2l antibody ( shows a clear temporal relationship with the early events of Cleavage of hRad21 during apoptosis. While examining the apoptosis when the cell membrane remains intact. Annexin V expression of Rad2l in mammalian cells after DNA damage, is a calcium-dependent, phospholipid binding protein with we surprisingly identified the cleavage of hRad21 protein after high affinity for phosphatidylserine (PS) and can be used to induction of apoptosis. hRad21 was cleaved during etoposideidentify apoptotic cells with exposed PS. As PS exists in the induced apoptosis in human Molt4 T-cell leukemia cells. Ininner face of the cell membrane in normal cells, Annexin V duction of apoptosis resulted in the generation of approxicannot bind to the cell membrane. Early in apoptosis, however, mately 64-and 60-kDa cleavage products, as determined with PS is translocated from the inner to the outer surface of the an hRad21 mAb (Fig. 1) . The cleavage of hRad21 in Molt4 cell membrane. As Annexin V has high affinity for PS, it can cells was a function of etoposide dosage (Fig. IA) , as the ratio then bind to the cell surface via interaction with PS. In the late of cleaved hRad21 to full-length protein appeared to be distages of apoptosis, Annexin V continues to bind PS, and as the rectly proportional to increasing doses of etoposide over the membrane permeability is increased, PI can enter the cell and tested range (10 to 50 p.M). hRad2l cleavage products were bind DNA. In addition to our results with Annexin V staining, we found that the progressive increase in the cleavage of u-tLamin hRad2l correlates with the level of active caspase-3 ( Fig. 2A) . were analyzed on an SDS-6% PAGE gel followed by Western blot were subjected to immunofluorescence staining and microscopy using analysis using hRad21 C-terminal pAb. Fig. 6C , antibody against myc tag (9Ei0) revealed the cleaved C-terminal Rad2l to the cytoplasm (Fig. 4, bottom proteins encoded by the transfected hRad2l WT and hRad21 panel).
ACS-mut-I and ACS-mut-Il constructs. However, the cleavage Inhibition of hRad21cleavage by caspase peptide inhibitors, fragments were detected only for WT hRad2l, not for either of Peptide-based caspase inhibitors inhibited the apoptosis-inthe mutants, indicating that a point mutation at D 279 prevented duced cleavage of hRad2i, suggesting the involvement of cleavage (Fig. 6C) . We reprobed the blot with anti-hRad21 caspases in hRad2l cleavage (Fig. 5 ). Molt4 cells were treated mAb and found that both the 60-and 64-kDa C-terminal with 20 p.M z-VAD-FMK, a broad-spectrum caspase inhibitor, fragments were present in all etoposide-treated cells (data not 1 h prior to etoposide (10 jiM) treatment. As shown in Fig. 5 , shown), confirming that endogenous hRad2l was cleaved in treatment with z-VAD-FMK completely blocked etoposidecells transfected with hRad2l mutants. induced hRad21 cleavage. In an in vitro cleavage assay (deInvolvement of caspases in hRad21 cleavage. Closer inspecscribed below), z-VAD-FMK also inhibited caspase-3-induced tion of the adjoining sequence at the Rad2l apoptotic cleavage cleavage of 35 S-hRad2l (data not shown).
site (DSPD 279 ) (Fig. 6A ) revealed a putative recognition seIdentification of the apoptotic cleavage site in hRad2l. The quence for a primitive caspase, Ced3. This sequence is conhRad21 cleavage site was mapped through N-terminal seserved Rad2l invertebrates, including humans, mice, and frogs quencing of the immunoprecipitated hRad2l cleavage prod-(Xenopus spp.). The sequence of the putative cleavage site, ucts from electroblotted and Coomassie-stained PVDF memtogether with the inhibitory effect of a panel of caspase inhibbranes (Fig. 6) . Sequencing of the 64-kDa band revealed that itors on etoposide-induced apoptosis in Molt4 cells, indicated hRad2l was cleaved at Asp-279 (D 279 ). The N-terminal sethe possible involvement of a caspase family protease. While quence of the 64-kDa band was SVDPVEP. In the full-length the experiments with caspase inhibitors suggested the involveprotein, the sequence immediately N terminal to the D1 79 ment of a caspase family of protease(s) in the pathway leading cleavage site was PDSPD 27 9 . Thus, there was a repeat of the to hRad2l cleavage, they did not demonstrate direct internal PDS sequence encompassing the cleavage site, i.e., PDSPD 2 79 i cleavage of hRad2l by a caspase. We therefore utilized an in SVDPVEP (Fig. 6A ). We were not successful in sequencing vitro cleavage assay as described previously for the retinoblas- -hRAD21) , or ACS mutants tagged with myc epitope at their N termini (pCS2MT-ACSmut-I or pCS2MT-ACSmut-II) and treated with etoposide as indicated. Lysates were analyzed with SDS-6% PAGE followed by Western blot analysis using antibody against myc tag (9E10) to distinguish the cleavage products from the native forms of transfected hRad21 WT and hRad2l ACS-mut-I and ACS-mut-ll proteins. toma protein (9) to examine the ability of purified caspase to _, cleave hRad21 (Fig. 7) . We used two caspases, caspase-3 and ,' caspase-7, that are major regulators of apoptosis in diverse cell 04 &P types (35) (Fig. 7A) , along with lysates from Molt4 cells treated A, B with etoposide (apoptotic lysate) or vehicle (nonapoptotic lya b c a b c a b c a b C sate), to examine their role in hRad21 cleavage (Fig. 7B) . kDa
Together, caspase-3 and caspase-7 comprise the caspase-3 sub-00 I h rd2.
family, and both enzymes recognize and cleave after the con- translated hRad21 in rabbit reticulocyte lysates clearly resulted -n hRad2 in the production of a 64-kDa hRad21 fragment ( Fig. 7A and  B) . The 64-kDa fragment produced by these caspases precisely  FIG. 7 . Cleavage of in vitro translated hRad2l by recombinant comigrated with the 64-kDa band produced by apoptotic caspase-3 and caspase-7. (A) In a cleavage reaction, in vitro translated Molt4 lysates, while the control (nonapoptotic) cell lysate unlabeled (nonisotopic) WT hRad21 or ACS mutant hRad21 (ACScould not cleave hRad21 protein. On the other hand, both of mut-I or ACSMut-II) in the rabbit reticulocyte lysate were incubated the hRad2i. ACS mutants failed to be cleaved by these two with saline (vehicle) (lanes a), caspase-3 (lanes b), or caspase-7 (lanes oheh Rd2 S ball i thiseassay, strongy ). TNT reactions in the absence of plasmid DNA served as a negative caspases or by apoptotic cell lysates in this assay, strongly control. Samples were analyzed on an SDS-6% PAGE gel followed by suggesting that caspase-3-or caspase-7-like enzymes in the Western blotting with hRad2l C-terminal pAb. Molecular weight Samples were resolved on a 4 to 20% gradient SDS-PAGE gel, were generated by caspase-3 and -7. It is possible that the fixed with methanol and acetic acid for 30 min, dried on a gel dryer, 64-kDa fragment was degraded further by these caspases, reand exposed to a Storm imager. sis assays, including examination of cellular morphology under light microscopy ( Fig. 9A ) and staining with TUNEL (Fig. 9B ), Annexin V (Fig. 9C) , and DAPI (Fig. 9D) , clearly indicated the ability of the 64-kDa C-terminal hRad21 to induce apoptosis. Quantitative analysis of 293T cells transfected with C-terminal hRad2l plasmids indicated a significant increase (P < 0.05) of nuclear degradation in cells transfected with the C-terminal < hRad21 hRad2l compared with that in cells transfected with vector control (pCS2MT), WT hRad2I (pCS2MT Rad21), or N-terminal hRad21 (pCS2MT hRad2l N-term) (Fig. 1A) . 1n these cells, apoptosis was also assayed by monitoring the phenotype of the DAPI-stained nuclei. As shown in Fig. 9D , cells transfected with hRad2l C-terminal plasmid displayed significantly more (P < 0.05) cellular and nuclear phenotypes typical of apoptosis, such as a round shape with shrunken cell volume, chromatin condensation, and nuclear disintegration, compared The proapoptotic activity of the C-terminal hRad2i was further strengthened by a significantly increased level (P < 0.05) of caspase-3 activity in Molt4 cells transfected with hRad21 C-terminal plasmids compared with that in cells trans-
FIG. 8. Cleavage of hRad21 in caspase-3-deficient MCF-7 breast
fected with the WT hRad2l (pCS2MT hRad2l) and N-termicancer cells. Apoptosis was induced by treatment of MCF-7 cells with nal hRad21 (pCS2MT hRad2l N-term) constructs. As shown 60 ilM etoposide for 6 h. Cells treated with DMSO (vehicle) served as in Fig. 10B , C-terminal hRad21 overexpression resulted in a a control. Whole-cell lysates or lysates from the cytoplasmic and nufive-to sevenfold increase in caspase-3 activity compared with clear fractions were electrophoresed on an SDS-6% PAGE gel and that of the empty vector control. Although overexpression of subjected to Western blot analysis using hRad2l mAb. Arrows indicate the hRad2l products.
WT hRad21 induced moderate but statistically insignificant levels of apoptosis, as determined by caspase-3 activity in Molt4 cells, overexpression of the hRad21 C-terminal cleavage product but not the N-terminal hRad21 cleavage product drasuiting in the production of smaller fragments. In the presence matically increased caspase-3 activity (P < 0.05) in Molt4 cells of caspase-7 but not caspase-3, a 95-kDa fragment of hRad21 (Fig. lOB) . The transfection efficiency in Molt4 cells was 35%, was also generated, suggesting another caspase site N-terminal as determined by cotransfection with a red fluorescence plasto the D 279 cleavage site. In the in vitro cleavage assay, mid, pDSRedl-mito. Similar results for caspase-3 activity were caspase-3 and -7 failed to generate the 60-kDa hRad21 fragalso obtained with MCF-7 and 293T cells transfected with ment that accompanies the 64-kDa fragment after induction of hRad2l constructs (data not shown). apoptosis, suggesting that the cleavage site generating the 60-Further experiments using vectors to direct hRad21 expreskDa fragment was not recognized by caspase-3 and -7.
sion either to the cytoplasm or nucleus demonstrated that To determine whether caspase-3 is essential for the in vivo expression of hRad21 in the cytoplasm but not in the nucleus cleavage of hRad21, we utilized a caspase-3-deficient MCF-7 resulted in the cleavage of hRad21 protein and induction of breast cancer cell line (21) . In experiments using etoposide-or apoptosis, as determined by assaying of caspase-3 activity (Fig. tamoxifen-induced apoptosis in MCF-7 cells, hRad21 cleavage 11). It is interesting that both the inyc-tagged (cytoplasmic) products were detected, indicating that caspase-3 was not eshRad21 and the WT (normally nuclear) hRad21 were cleaved sential for hRad21 cleavage (Fig. 8) and that a caspase other in the cells transiently transfected with the pCMV/myc/cytothan caspase-3 can act upon hRad21 to cause cleavage followhRad2l construct (Fig. 11) . In summary, the C-terminal ing induction of apoptosis.
hRad21 cleavage product was proapoptotic, as determined by hRad21 C-terminal cleavage product promotes apoptosis. A increased caspase-3 activity and apoptotic morphology, and its possible role for hRad2I in the induction of apoptosis was first translocation to the cytoplasm may play a role in promoting seen in preliminary experiments in which overexpression of apoptosis. These findings demonstrate the ability of the 64-hRad21 in Molt4, 293T, and MCF7 cells resulted in apoptotic kDa Rad2l fragment to induce apoptosis. In panels A to C, 293T cells were transiently transfected with CMV promoter-driven myc-tagged mammalian expression plasmids (pCS2MT) encoding the full-length hRad2l or cDNAs encoding the two cleavage products, hRad21 N-terminal (aa 1 to 279) and hRad21 C-terminal (aa 280 to 631) proteins. In panel D, in addition to the above constructs, cells were also cotransfected with a red fluorescence plasmid (pDsRedl-Mito) to account for the hRad21-transfected cells. Note that C-terminal-hRad2l-transfected cells have round morphology, as shown in light micrographs (A) and are positive for TUNEL (B) and Annexin V (C) staining (arrows). PI was used to detect the integrity of cell membranes in Annexin V-FITC staining; hence, the nuclei of some apoptotic cells were red (arrowhead). In panel D, more than 50% of the C-terminal-hRad2l-transfected cells with red fluorescence have fragmented nuclei and condensed chromatin, typical of apoptotic cells.
cycle and apoptosis, we examined the role of p53 in the apovarious agents, including DNA-damaging (ionizing radiation ptotic cleavage of hRad2l. We used two myeloid leukemia cell and topoisomerase inhibitors) and non-DNA-damaging agents lines, ML-1 and HL-60, with WT and null p53 genotypes, (cycloheximide treatment, cytokine withdrawal, and treatment respectively (32, 41) . Apoptosis was induced using UV (20 with proteasome inhibitors). We have biochemically mapped J/m 2 ) and ionizing radiation (20 Gy) in these cells. As shown in the apoptotic cleavage site in human Rad2l (PDSPD. 79 /S), Fig. 12 , the induction of apoptosis resulted in the cleavage of which is distinct from the mitotic cleavage sites (DREhRad21 protein in both cell lines, indicating the lack of a role IMR 7 2/E and IEEPSR 450 /L) previously described (12) . The for p53 in hRad21 cleavage. apoptotic cleavage site is conserved among vertebrate species, and it is likely that cleavage is mediated by a nuclear caspase or DISCUSSION caspase-like molecule, as this cleavage site bears the characteristic caspase-3 subfamily recognition motif (DXXD) and Sister chromatid cohesion during DNA replication plays a hRad21 is cleaved in vitro by the two major apoptosis execupivotal role in accurate chromosomal segregation in the eutioner caspases, caspase-3 and caspase-7. hRad21 cleavage is karyotic cell cycle. Rad2l is one of the major cohesin subunits not restricted to transformed cancer cells, as induction of apthat keeps sister chromatids together until anaphase when optosis resulted in hRad21 cleavage in the primary cell line proteolytic cleavage by separase allows the chromosomes to IMR90 (data not shown) as well as the nontransformed imseparate. Mitotic cleavage sites in Rad2l in yeast as well as in mortal cell line EL-12. humans have been mapped (12, 37, 39) . Here we show that
Cleavage of hRad21 appears to be an early event in the hRad2l cleavage occurs during apoptosis and is induced by apoptotic pathway. The immunofluorescence experiments and 
S600
myc/nuc-hRad21, which direct the expression of the recombinant protein to the cytoplasm and nucleus, respectively. Empty PCMV/myc/ .500 cyto vector served as a control. At 48 h posttransfection, protein lysates d, 49 were made and subjected to Western blot analysis using c-myc epitope a-(9E10) and hRad21 mAb to detect the fusion and/or native hRad2l
proteins, respectively. Lysates were also used for the assaying of and apoptosis. As determined by Annexin V staining, hRad21 transiently transfected with CMV promoter-driven myc-tagged mamcleavage correlates well with the early events of apoptosis malian expression plasmids encoding the full-length hRad21 or cDNAs when the cell membrane remains intact. Furthermore, the proencoding the two cleavage products, hRad2l N-terminal (aa I to 279) gressive increase in the cleavage of hRad21 correlates well with and hRad21 C-terminal (aa 280 to 631) proteins. 293T cells were also cotransfected with the red fluorescence plasmid pDSRedl-mito to the level of caspase activation, as determined by assaying of by account for the hRad21-transfected cells. Nuclear degradation of 293T caspase-3 activity. Translocation of the 64-kDa hRad21 cleavcells (A) and caspase-3 activity in Molt4 cells (B) were measured as age product to the cytoplasm early in apoptosis may act as a described in Materials and Methods. For the nuclear degradation nuclear signal that promotes and accelerates subsequent assay, cells were collected and fixed 24 and 48 h after transfection. The samples were stained with DAPI and examined with fluorescence mievents of apoptosis. The specificity of this product was detercroscopy. Cells with fragmented nuclei or condensed chromatin were mined further, as the N-terminal hRad21 cleavage product counted as apoptotic. For each sample, a total of 50 intact and deneither translocates nor has the ability to induce apoptosis. We graded nuclei of cells coexpressing pDsRedl-mito (with red fluoreshave not explored the role of the 60-kDa hRad2l product cence) was counted. Each data point represents the average and standard errors of the mean from three experiments. The data for generated at a cleavage site other than D 2 79 /S in the apoptotic caspase-3 activity shown in panel B are the averages and standard process. errors of the mean from two experiments. The results of the apoptosis
The physiological significance of cohesin hRad21 cleavage in assay were analyzed using a binomial test of proportions and those for apoptosis is intriguing. The nuclear signal(s) that detects subcaspase-3 activity were analyzed using Student's I test. Data labeled "a" sequent events of apoptosis in the cytoplasm and mitochondria are significantly different (P < 0.05) from data labeled "b."seunevtsoaptsiinhecolsm nd iohnda has remained elusive. It is possible that cleavage of hRad21 at the onset of apoptosis and the translocation of the C-terminal cleavage product to the cytoplasm act as cues to accelerate the Western blot analysis of nuclear and cytoplasmic fractions of apoptotic process. Supporting evidence in favor of this possicells undergoing apoptosis demonstrate the translocation of bility include the following: (i) hRad21 is not normally cytothe hRad21 C-terminal cleavage products to the cytoplasm plasmic; (ii) early in apoptosis, hRad2l is found in the cytoearly (3 to 4 h after insult) in apoptosis. Our results clearly plasm; and (iii) directed expression of either the C-terminal or show that hRad21 proteolysis by a caspase family protease at full-length hRad21 to the cytoplasm induces apoptosis. It is not D 279 /S leads to the production of a proapoptotic C-terminal clear whether localization of C-terminal hRad21 to the cytocleavage product. The specific protease that cleaves hRad2l in plasm is due to an active or a passive transport process followvivo and promotes hRad2i-induced apoptosis is yet to be idening cleavage. The carboxy-terminal fragment contains a putatified. Nuclear changes determined by Annexin V staining and tive nucleolar localization signal sequence, which argues examination of the morphology of DAPI-stained nuclei indiagainst a passive transport process. These findings further cate a strong temporal relationship between hRad2l cleavage strengthen the notion that the translocation of the C-terminal . strate vimentin has recently been described (3). The p53 tumor suppressor protein plays a central role in the regulation of the cell cycle and apoptosis after DNA damage (17, 34) . In the event that DNA damage is more severe and not repairable, p53 directs the cells into apoptosis through the
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Cleaved
BaxIBcl-2 pathway. p53 status does not appear to have any hRad2l effect on the apoptotic cleavage of hRad21 after DNA damage (i.e., UV and ionizing radiation), indicating the lack of involvement of the p53 pathway in hRad21 cleavage. It is possible that a parallel p53-independent pathway may regulate the geno- suggesting an evolutionarily conserved mechanism shared by treatment, protein lysates were made and resolved by SDS-6% PAGE followed by Western blot analysis using hRad21 mAb. Arrows indicate the mitotic and apoptotic machinery. hRad21 may serve as the hRad2l cleavage products. C, control without UV or IR treatment.
link between the two key cellular processes of mitosis and apoptosis. In summary, in contrast to the previously described functions of Rad2l, i.e., in chromosome segregation and DNA hRad21 protein to the cytoplasm may play a functional role in repair, cleavage of the cohesion protein and translocation of apoptosis.
the C-terminal cleavage product to the cytoplasm are early We have firmly established the proapoptotic activity of the events in the apoptotie pathway that amplify the apoptotic C-terminal hRad21 cleavage product by several apoptotic assignal in a positive-feedback manner, possibly by activating says, including Annexin V staining, TUNEL methods, quantimore caspases. These results provide the framework for identative measurement of DAPI-stained nuclear morphology, and tification of the physiologic role of hRad2l in the apoptotic assaying of caspase-3 activity. However, the exact mechanism response in normal and malignant cells. by which cleaved hRad21 induces apoptosis requires further investigation. It is interesting that a BLAST search of the ACKNOWLEDGMENTS apoptosis database (www.apoptosis-db.org) indicated that CWe thank T. Nagase (Kazusa DNA Research Institute, Chiba, Jaterminal hRad21 possesses a stretch of 80 aa (aa 282 to 362) pan) for the KIAA0078 (SK-hRad2l) plasmid, J.-M. Peters (Research that has homology to the tumor necrosis factor receptor suInstitute of Molecular Pathology, Vienna, Austria) for the Rad2l perfamily and other apoptosis-inducing proteins, including N-terminal pAb, and D. Medina (Baylor College of Medicine) for the TRAIL-R2 and death receptor 5. However, the functional EL-12 cell line. We thank Lisa Wang for critically reading the manusignificance of this domain in apoptosis-inducing proteins is script and Sara Ekhlassi for technical assistance. This study was supported by grants from the U.S. Army Medical not known.
Research and Materiel Command (DAMD-17-00-1-0606, DAMD-01-The caspase-mediated proteolysis of hRad21 and the partial 1-0142, and DAMD 01-1-0143 to D.P. and DAMD-17-97-1-7284 and removal of hRad21 from the nucleus may also expose the DAMD-17-98-1-8281 to S.E.P.). chromosomal DNA to DNase and other proteins responsible for chromatin condensation and apoptotic DNA fragmenta-ADDENDUM IN PROOF tion. hRad21 was originally isolated in fission yeast as an essential protein with a role in the repair of DNA double-strand A similar conclusion regarding the function of RAD21 in breaks induced by ionizing radiation (2) Aneuploidy is a common characteristic of tumors (9-11) and has possible mechanism of hormone-induced aneuploidy. Hormones increased also been proposed as a necessary event for tumorigenesis (11, 12) . proteins were not increased in hormone-stimulated p53-null compared generating aneuploidy are thought to be diverse, but all involve with WT cells. ESPLI RNA was also increased in p53-null mouse mammary cells in vivo by 18 h of hormone stimulation and in human breast deregulation of some aspect of chromosomal replication and segre-MCF7 cells in monolayer culture by 8 h of hormone stimulation. Furthergation (17) . The mechanisms may be very specific, as in alterations of more, both promoters contained p53 and steroid hormone response elecentrosome replication (18) and fidelity of the spindle apparatus, or in ments. Mad2 protein was increased as a consequence of the absence of p53 regulation of sister chromatid separation during mitosis (17) . Addifunction. The increase in Mad2 protein was observed also at the cellular tionally, the mechanisms may be passive, such as increased mitogenlevel by immunohistochemistry. Second, hormones increased gene ampliesis that leads to increased frequency of cells with missegregated cation in the distal arm of chromosome 2, as shown by comparative chromosomes in the absence of normal cellular checkpoints (17, 19, genomnic hybridization. These results support the hypothesis that hormone 20). Finally, the mechanism might be nonspecific and generated as a stimulation acts to increase aneuploidy by several mechanisms. First, by result of random DNA damage. Estrogens are genotoxic in certain cell increasing mitogenesis in the absence of the p53 checkpoint in G 2 , hormones allow the accumulation of cells that have experienced chromosome types, such as the rodent kidney cell (21, 22) and produce DNA missegregation. Second, the absolute rate of chromosome missegregation adducts and mutations. may be increased by alterations in the levels of two proteins, separase and Both p53 heterozygous and p53-null mouse mammary epithelial Mad2, which are important for maintaining chromosomal segregation and cells are at increased risk for tumorigenesis (23, 24) . The tumors are the normal spindle checkpoint during mitosis.
aneuploid and metastatic, and the pathogenesis mimics that observed in human breast cancer (25) . The absence of p53 gene function does INTRODUCTION not significantly disturb normal mammary development, measured either morphologically (8, 26) or functionally (27) . However, horGenetic instability is a frequently reported event in p 53 gene-mone stimulation of the gland increases not only tumorigenic risk but deleted cells. The genetic instability observed in both normal and also the frequency of aneuploid cells (8). The mechanism of this tumor cells of p53 knockout mice is evidenced by high incidences of honnone effect has not been established. In the experiments reported aneuploidy (1, 2), centrosome amplification (2, 3), and loss of het-herein, we examine the possible cellular mechanisms for hormoneerozygosity (4, 5) . The frequency of these events is dependent on cell induced aneuploidy and conclude that the effect is both indirect type and on specific cell stimuli. For example, inactivation of p53 in because of increased mitogenesis and direct because of increased the diploid human colorectal cancer cell line HCT116 generates expression of two proteins involved in regulating chromosome segneither aneuploidy, chromosomal instabilities nor increased sister regation, separase (ESPLJ) and Mad2. chromatid exchange (6) . In a mouse transgenic model for choroid plexus tumors, absence of p53 does not generate chromosomal imbalances as measured by comparative genomic hybridization or flow MATERIALS AND METHODS cytometry (7). In the absence of p53, aneuploidy and centrosome amplification are common occurrences in cell cultures of fibroblasts Transplantation All of the mice were bred and maintained in a conventional mouse facility weeks. In each experiment, at least one fat pad was processed as a whole (713) 798-4483; Fax: (713) 790-0545; E-mail: dmedina@bcm.tmc.edu. mount at 8 weeks to examine the growth and morphology of the outgrowth MECllANISMS OF IIORMONE-INDUCED ANEUPIOIDY (23) . The remaining transplanted samples were examined as described below tories, Burlingame, CA), and the digoxigenin-labeled control DNA was visufor the individual experiments.
alized with a mouse antidigoxigenin antibody (Sigma, St. Louis, MO), folIn experiment 1, the proliferative and apoptotic indices of WT and p53-null lowed by a goat antimouse antibody conjugated to tetrarnethylrhodamine normal mammary glands in the presence and absence of hormonal stimulation isothiocyanate (Sigma). Chromosomes were counterstained with 4',6-diawere examined using two different protocols. In both approaches, samples of midino-2-phenylindole and embedded in antifading agent to reduce photothe p53 WT normal duct and the p53-null normal duct were transplanted into bleaching. Gray scale images of the FITC-labeled test DNA, the tetramethylthe contralateral fat pads of each mouse. The first approach was a modification rhodamine isothiocyanate-labeled control DNA, and the 4',6-diamidino-2-of an earlier experiment where the transplanted epithelium was subjected to a phenylindole counterstain for at least 15 metaphases/sample were captured 5-week period of hormone stimulation starting two weeks after transplantation with a cooled charge-coupled device camera (CH250; Photometrics, Tucson, (8). In this modification, a silastic tubing containing estrogen (50 dig) plus AZ) connected to a Leica DMRBE microscope equipped with fluorochromeprogesterone (20 mg) was used instead ofa pituitary isograft as in the original specific optical filters TRI, TR2, and TR3 (Chroma Technology, Brattleboro, experiment. A pituitary isograft results in marked increases in the circulating VT). Quantitative evaluation of the hybridization was performed using a levels of prolactin and progesterone (28) . Five transplants were collected from commercially available comparative genomic hybridization analysis software the hormone-treated and untreated control mice for BrdUrd-labeling index. In (CW4000CGH). Average ratio profiles were computed as the mean value of at the second approach, the mice were untreated until 8 weeks after transplantaleast 8 ratio images and were used to identify changes in chromosome copy tion, when the transplanted ducts had filled the mammary fat pad and were number. entering into a steady growth state. The animals were divided into three groups: untreated, received a silastic tubing containing estrogen (50 11g) and Western Blots progesterone (20 mg), or untreated. Two-three transplants floro each group Wes were collected at 3 and 4 weeks thereafter and examined for morphological Weser blot analysis of the effectl of hormoae stimulation on the expression devecolloentedat, 3
Br d4dweeksthgrindex, and apoptot inede forof mitotic proteins involved in sister chromatid cohesion and separation was performed as described in Ref. 33 . Briefly, after five weeks of hormone Cell Culture stimulation, the mammary glands containing transplants of both genotypes were collected, the epithelial cells were isolated and concentrated by gentle MCF-7 cells contain WT p53. The MCF-7 cells were seeded in improved enzymatic treatment as described in Ref. 34 , and the epithelial cell pellet minimal essential medium (IMEM) supplemented with 5 ,tg/ml bovine insulin processed for protein evaluation. The protein lysate was prepared as described and with 5% charcoal stripped serum for 24 h then in serum-free IMEM for previously (33) . Cell pellets or tissue samples were lysed in radioitniunopreanother 48 h. Cells were exposed to hormones or left untreated in fresh cipitation assay buffer (PBS, 1% NP40, 0.1% SDS, and 0.5% sodium deoxyserum-free media and harvested at 0, 0. 10-15 mrin on ice, followed by passage through a 21G needle. When approsamples were fixed in cold 4% paraformaldehyde for I h before being propriate, additional phosphatase inhibitors cocktail l and II (Sigma-Aldrich) were cessed for paraffi n-ernbedded sections. The antibody to BrdUrd was BD praeadionlhshts niboscckilInd1(SgiArei)we cs frar affg In Sin-embeddedtsections.it The antibody , to ll BrDig wAs . B added to the lysis buffer at a dilution of 1:100. Lysates were then centrifuged PhiarMingen BrdUrd In Situ Detection Kit (BD Biosciences, San Diego, CA).
at 1000 X g for 20 min, and the supemnatants were aliquoted and frozen at Animals were injected with BrdUrd (50 mng/kg body weight) 2 h before at10Xgfo20mnadthsueaatswr lqtdadfoznt sanrifime.Atleastfiveseparatesamples were injec0 mgg bod eighout) oh b e -80'C until use. After protein quantification (using detergent compatible sacrifice. At least five separate samples were examined for each outgrowth line protein dye and BSA standards from Bio-Rad; Hercules, CA) and normalizafor each assay.
tion, 30-40 Mtg of protein extracts were electrophoresed on SI)S-PAGE gels Apoptotic Index and transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA). The filters were initially blocked with 5% nonfat-dry milk in Tris buffer Samples of transplant generations 7-8 were fixed in 10% neutral buffered saline containing 0.1% Tween 20 for 1-2 h at room temperature and then forinalin, embedded and stained with Il&E, and evaluated for apoptotic indices probed with hseparase mAb(l:500), p55CDC(1:500), Cdhl(1:500), mouse by the terminal deoxynucleotidyl transferase-mediated nick end labeling secturin(1:250), hBubl(l:500), Mad2(1:500), hRad21(l:100), cyclin BI(I: method (30) . For this assay, at least 3 samples were read per outgrowth and 500), Cdc2(l:1000), cyclin E(l:5000), Rad5l(l:500), and P-actin antibod-500 cells counted per slide. ies(l:100,000). All of the antibodies except hRad2l, hCdhl (Neumarkers, Fremont. CA), and hseparase (a gift from Jan-Michael Peters, Research InstiGenetic Analysis tute of Molecular Pathology, Vienna, Austria) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). The bound antibodies were visualized Cytogeneti Analysis. Samples of the p53-null and p53 WT normal mainby the enhanced chemiluminescence detection system (Amersham, Buckmary cells, both untreated and hormone-stimulated, as well as p53-null priinghainshire, England) in combination with the horseradish peroxidasemary tumors were evaluated for chromosome number and cytogenetic changes conjugated antimouse or antirabbit secondary antibodies as appropriate, and using conventional cytogenetic techniques as described in Ref. 8. For each intensity of the specific bands in the exposed films was quantified. In some of preparation, 50 rnetaphases were counted. The types of cytogenetic changes the later studies, bound primary antibodies were detected with IRD800 dyeexamined included breaks, dicentrics, translocations, and aneuploidy.
labeled appropriate species-specific secondary antisera, and signal was visuComparative Genomic Hybridization. Comparative genomic hybridizaalized on a Li-Cor Odyssey IR scanner (Lincoln, NE). tion was performed on the hormone-stimulated mouse mammary epithelial cells of p53 WT and p53-null genotype. Each individual sample was composed Northern Blots of epithelial cell pellets isolated from three mammary fat pads. Comparative genomic hybridization was performed as described previously (31, 32) . NorTotal RNA was isolated using RNeasy mini kit from Qiagen. Fifty micromal control DNA was prepared from spleen tissue of normal mice, and test gram's of total RNA were diluted in X2 RNA sampling buffer [20% formal-DNA was prepared from p53-/-and p53 +1+ mammary cells, using standdehyde; 1.65% Na2,HP0 4 (pH 6. P]CTP-labeled ESPLI eDNA mosomes prepared from a karyotypically normal mouse. The biotin-labeled probe for 2 h, the membrane was washed 15 min twice with 1 washing buffer test genome was visualized with avidin conjugated to FITC (Vector Laboracontaining 300 mm NaCL, 30 mm sodium citrate, and 0.05% SDS at room
Effect of Hormones on Cell Proliferation. It is well established that both estrogen and progesterone induce cell proliferation in the normal mamrnmary gland although to different extents and in different cell compartments. Therefore, the induction of aneuploidy in the p53-null cells by only low doses of progesterone was unexpected (8). We examined the effects of estrogen and/or progesterone on cell 5 -proliferation as a function of time of exposure. Examination of the 4 -4 whole mounts indicated that the two cell genotypes responded in a S3 similar manner to the hormones. In the untreated mice, the mammary 2 cells were organized as well-spaced primary and secondary ducts. The 1 absence of hormones (ovariectomy) resulted in ducts with very nar-0 .. row lumina, thus giving the appearance of atrophic ducts. The effect UrntY, Untp53/-E+PAWT E+P153-fof estrogen was to increase slightly ductal density and to increase the size of the duct lumina. The effect of progesterone was distinct from estrogen because it led to an increase in small duct branching but only The proliferation results are shown in Figs. I and 2 . Three results are of interest. First, it is evident that the p53-null cells had a similar proliferative activity as the p53 WT cells at 7 weeks (Fig. 1) and at 11-12 weeks (Fig. 2) posttransplantation. The former time period tto-t represents cells approaching a steady state (80% fat pad filled) and the latter time period a maintained steady state with respect to proliferation. All of the three hormone treatments increased the proliferative f0 activities of both the WT and null cells. The absolute percentage increases were the same for the WT and null cell phenotypes and were 4.1-and 3.5-fold, respectively, in estrogen-treated cells (Fig. 2) , 4.9-. and 4.7-fold, respectively, in progesterone-treated cells (Fig. 2) , and S4 7.8-and 8.3-fold, respectively, in estrogen-progesterone treated cells (Fig. 1) . Thus, there was little evidence of increased susceptibility of The apoptotic indices were evaluated at 3 weeks after hormone stimulation. Apoptotic activity was low (:5 1%) and was not different temperature followed by two washes with wash solution containing 15 tM with respect to hormone treatment or p53 status (data not shown). NaC1, 1.5 mm sodium citrate, and 0.1% SDS at 50'C for 20 min each. Blots
The results of the cytogenetic analyses are shown in Table I and were visualized on a phosphor screen, and bands were quantitated on a Fig. 3 . Wild-type normal mammary cells were not examined, because STORM Imager (Molecular Dynamics). The membrane was then stripped such cells are uniformly diploid and rarely show aberrations (8). The (0,1 X saline sodium citrate and 1% SDS) and rehybridized with keratin 18 or P-actin probes as a control. The absorbance of the bands was quantified using ImageQuant software, and the values were normalized relative to the control. (separase and securin) or increased in posttranslated modified forms (p55CDC, Cdhl, and Mad2) as a consequence of hormone 10! stimulation. BubI was decreased significantly (Fig. 5A) . The effect of hormones on mitotic-related proteins appeared to be selective as 0 expression of a number of other proteins involved in various transplants (Mad2) and hormone-stimulated transplants (Mad2 and separase; Fig. 5C ). Of interest, securin was not increased additionpseudodiploid cell populations were those defined as 41-42 chromo-ally in hormone-stimulated p53-null cells compared with hormonesome number. As expected, the number of aneuploid cells increased stimulated WT cells (Fig. 5D) . The quantitative analysis of these with hormone stimulation and was greatest in the tumors. The fre-changes is shown in Fig. 5D . quency of chromosome aberrations increased slightly in the pseudoTo determine whether the increase in protein reflected a direct diploid cells but did not accumulate to larger numbers in the aneuploid effect of hormones on gene expression or an indirect effect because of "normal" cells or tumors. This difference was not statistically signif-alveolar cell differentiation over the 5-week period, we evaluated the icant when analyzed by ANOVA. Thus, it appeared that chromatid mammary transplants after short-term hormone stimulation. Seven and chromosome aberrations reflected the underlying state of genetic weeks after transplantation, mice were exposed to chronic hormone instability in the p53-null cells but were not correlated directly with treatment (50 Ag E2 and 20 ing P) via silastic implants, and 8 mice aneuploidy. We interpret these data, along with unpublished sister were exposed to blank implants. At 18 and 48 h of hormone stimuchromatid exchange results, to indicate that the hormonal induction of lation, the transplants were collected, epithelial cell pellets prepared, aneuploidy was not a direct consequence of hormone-induced DNA and RNA isolated. Northern blot analysis revealed marked increases damage.
(->4x) in ESPLI mRNA at 18 and 48 h posttreatment compared with The results of the comparative genomic hybridization studies are controls (Fig. 6) . shown in Fig. 4 . The hormone-stimulated (via pituitary isograft)
To obtain a more precise picture of the time course of honnonep53-null cells showed an average of 7. 
Cdc2
human ESPLI (encodes separase protein) and MAD2 genes for po-I G2) tential transcription start sites and potential transcriptional factor 4-Idhl binding site (Fig. 8 ) using bioinformatics tools (35) ." In mouse 4110 JAP atr 41 ESPL I, we identified a strong promoter sequence with a score of 0.99
(a score of 0.85 has a 0.1-0.4% false positive prediction rate; Fig. 8A ). 4 
'•"
•results, together with previous results demonstrating a similar degree -4 , ,,of dependence on these ovarian hormones for growth in ovariectomized mice as well as for tumor development (36) , argue strongly that the cellular responses to these hormones with respect to control of hESPLI proliferation are nornal and should not be considered as dysregulated.
1mir NA Additionally, analysis of the RNA transcriptome demonstrates that the 4" ACTIN p53-null mammary cell responds normally to these hormones with respect to milk protein synthesis (27) . Thus, an altered proliferative response is not likely the cause of the marked increase in aneuploidy.
B E2+P treitmrnt (hug)
Second, the hormone-induced aneuploidy in the p53-null cells was not correlated with increases in chromosomal breaks, dicentrics, or 0 0.5 2 S 20 49 translocations, which are markers for DNA damage. The lack of any increase in DNA damage as determined by two different assays (sister S0ý hESPLI chromatid exchange and oxidative damage) also does not support the 1.0L '-mRNA idea that the hormones were increasing these biochemical events." * KERATINI.1 Previously, we ruled out the mechanism of centrosome duplication (8) as a source of aneuploidy; thus, the data thus far suggest that these two mechanisms (i.e., DNA damage and centrosome duplication) are not o500 population. An increased frequency of proliferation would shorten the 48 h, and treated with ethanol (vehicle) or P (10 rM), E2 (10 n; .4), or E2+ P (10 nM each; B) in fresh seram-free media as indicated. The mRNA levels were determined as described time for aneuploid cells to accumulate in the cell population. This in the text below. Time course of the combined treatment of E2 and P at a dose of 10 nm scenario is exactly what is indicated by our results. In the virgin each on the expression of hESPLI mRNA in MCF7 cells. Keratin-18 is shown as loading control. Bottom panel B represents relative hIESPL mRNA levels from two independent animal, proliferation is low, and the appearance of detectable aneuexperiments with respect to the housekeeping gene keratin-18 that was normalized and ploid cells increases with host age so that there is no detectable presented as % control; bars, :SE. Values associated with dissimilar symbols are aneuploidy in p53-null cells at 8-14 weeks of age but low levels of significantly different (P < 0.05 from one another.
aneuploidy at 22-26 weeks of age (8). With hormone-induced increases in proliferation in p53-null cells, there is a marked induction we pursued this observation using immunohistochemistiy of normal of aneuploidy. Importantly, there is no aneuploidy in p53 WT cells. and tumor tissues. Fig. 9 illustrates the patterns of MAD2 expression These results raise the question whether the absence of p53 confers and localization. Mad2 is detectable at low frequency and intensity of merely a passive mechanism for generation of aneuploidy or whether staining in normal cells of p53 WT and p53-null (Fig. 9A) . However, p53 is more directly involved by altering the transcriptional regulation in small hyperplasias (Fig. 9, A and B) , Mad2 frequency and intensity or functional activities of genes that are important for proper chrois markedly increased, and localization in the cytoplasm as well as the mosomal segregation. There have been considerable advances in nucleus becomes apparent. In tumors, Mad2 continues to be highly understanding the genes involved in sister chromatid separation and expressed, and cytoplasmic localization can be significant (Fig. 9 , C chromosome segregation (17) . The relationship between p53 and the and D). genes involved in regulating chromosome segregation is not well established. The results reported herein indicate that the levels of
DISCUSSION
several proteins important for the regulation of orderly sister chromatid separation are increased in mitosis. More importantly, the levels of
The presence of aneuploidy in tumor cells is undisputed. However, two of these proteins (Mad2 and separase) are increased in hormonethe significance of aneuploidy as an obligatory mechanism of tumor-treated p53-null cells compared with hormone-treated p53 WT mamigenesis and tumor progression is controversial (15, 16) . In an earlier mary cells. Hormone treatment also increased separase RNA expresstudy, we reported that honnones greatly increased the frequency of sion. The increase in separase RNA was observed in normal p53-null aneuploidy in normal mammary cells that had lost the p53 tumor mouse cells in vivo by 18 h and in p53 WT MCF7 human cancer cells suppressor gene (8). Additionally, these same hormones increased the in vitro by 8 h. These results support the idea that hormones were frequency of tumorigenesis, and the resultant tumors were also highly directly causing an increase in separase gene expression. The signifaneuploid (36) . Beyond this initial correlation, the possible mecha-icance of the increase in separase is inferred from the knowledge of its nisms by which hormones might induce ancuploidy were not addressed. The results described herein address this major question.
" function, because separase activity is necessary for sister chromatid Are the effects of hormones more encompassing than just increased separation (17) . A direct effect of estrogen on Mad2 gene expression levels of separase and Mad2 driving chromosome missegregation? has been reported also by an in vivo study in mouse uterus using We have tried to assess this question using two different approaches. microarray analysis, where a 6.5-fold increase in Mad2 RNA was First, analyzing the pattern of chromosomal gains and losses by reported after estrogen treatment (39) .
comparative genomic hybridization revealed one consistent chromnoInterestingly, securin and Rad2l protein levels were not increased somal alteration in hormone-stimulated p53-null cells compared with in the hormone-stimulated p53-null cells compared with the hormonehormone p53 stimulated WT cells. The most consistent change ocstimulated WT cells. Securin is already elevated as a consequence of curred in the distal region of chromosome 2, a region in the mouse honnone stimulation; however, Rad2l protein remains at basal levels, harboring genes such as MMP9, kinesin, P3-2 microglobulin, and If securin and separase are high, one might predict lower levels of intracisternal A particles. This region is syntenic to human chromoRad2l because of the increased protease activity represented by some 20q1 1.21 and 20q13. 32 . Genes of interest in this region include separase. One explanation for this paradox might be found in the aurora kinase A, breast carcinoma amplified sequence 1, ubiquitindynamics of Rad2l localization in mammalian cells. The majority of related protein sumo-l, protein tyrosine phosphatase 1B, and Rad2l dissociates from the centromere in prophase and localizes as CCAAT/enhancer binding protein P3. We are examining the expresunbound protein in the nucleoplasm (40). The cleaved protein from sion of some of these genes at the protein level; namely, aurora kinase the centromere will represent a small fraction of the total Rad2l pool A and CCAAT/enhancer binding protein 3. and is unlikely to alter the signal detected by the antibody on a
The second approach used was serial analysis of gene expression, Western blot. Alternatively, the increased separase protein may repwhich showed alterations in -1% of the transcriptome of the horresent a catalytically inactive protein. This question remains to be mone-stimulated p53-null mammary cells (27) . These genes included answered, known p53-regulated genes such as gelsolin, Gadd45b, and lgfbp5, Why the two proteins (Mad2 and separase) are differentially reg-and other genes not thought to be directly regulated by p53, such as ulated by p53 is explained by the analysis of the respective promoters intracisternal A particles, MMP9, 03-2 microglobulin, and wdnml of the two genes. Both promoters contained p53 and steroid hormone (27) . The first three of these genes are located on the distal arni of response elements. The ESPLI promoter differed from the MAD2 chromosome 2. The role of any of these genes in regulation in sister promoter in the additional presence of a p53 transcriptional activation chromatid separation and/or mitosis is not suspected. element. Analysis of p53-regulated gene expression from a published
The amplification of intracisternal A particles, a gene that is a study using oligonucleotide arrays identified MAD2 as one of the transposon, suggests another possibility for generating aneuploidy genes that is repressed by p53 (41) . Previous observations suggest that and/or increased RNA expression of the genes. The gain of this region the p53 transcriptional repressor element sequence can modulate was also observed as increases in intracistemal A particles by electron p53-dependent transcriptional activation in a position and promoter-microscopy. 1 2 The increase in transposon activity has been shown to independent manner (37) . These results support the hypothesis that in activate specific gene functions in other mouse models of mammary WT mammary cells, p53 can act to dampen steroidal induction of tumorigenesis (49, 50) . separase and Mad2 gene transcription. In the absence of p53 function, Based on the current accumulated data, we are proposing that steroid hormones manifest their uninhibited effects by significant hormone facilitation of aneuploidy in p53-null mammary epithelial induction of ESPLI and MAD2 gene expression that facilitates ane-cells occurs by several mechanisms. First, we suggest that hormones uploidy. The physiological significance and mechanism of p53 re-have an indirect role in the induction of aneuploidy by markedly pression and its coregulation, if any, with the p53 activation binding increasing the mitotic frequency of these normal cells and a direct role elements is yet to be elucidated, by increasing the expression levels of proteins regulating chromosome The significance of elevated Mad2 is more difficult to understand segregation. We hypothesize that the absence of p53 function results because this protein functions to inhibit the anaphase promoting in both an aberrant separase activity and an aberrant G 2 checkpoint complex, and the functional activity of the latter complex is necessary that together allows the accumulation of cells with aneuploidy as a for releasing separase activity (17) . Haploinsufficiency of Mad2 re-function of time and mitotic frequency. The presence of aneuploidy sults in chromosome instability (42) . Also, the appropriate functioning has an indirect effect on tumorigenesis by increasing stochastically the of the spindle checkpoint requires a critical ratio of Mad1 and Mad2 frequency of altered expression of genes involved in growth regulato ensure a pool of Madl-free Mad2 (43) . An excess of Mad2 as well tion and invasiveness. Second, we speculate that hormones specifias insufficient Mad2 might result in an altered spindle checkpoint.
cally increase expression of genes localized in the distal region of Another possibility is that the increased form of Mad2 is an inactive chromosome 2, which contains genes related to control of chromoform, but this remains to be tested experimentally. Finally, it is some segregation (e.g., aurora kinase A), as well as genes involved in possible that the increased levels of Mad2 are only related indirectly premalignant progression (e.g., CCAAT/enhancer binding protein /3 to the increased aneuploidy but rather have effects on other cellular and SUMO-1). Future experiments will test these hypotheses. functions (44-46). It has been reported recently that increased levels of Mad2 are present in gastric tumors (47) and ovarian tumors (48) . ACKNOWLEDGMENTS The results reported herein demonstrated increased levels of Mad2 in mammary hyperplasias and tumors. Additionally, the localization of We are grateful for the assistance of Dr. Susan Hilsenbeck in the statistical Mad2 in these lesions was both nuclear and cytoplasmic compared analysis of the data and Jan-Michael Peters for the antibody to separase. with just nuclear in normal cells. These results along with reported interactions of Mad2 with proteins thought to be unrelated to control of mitosis (44-46) suggest that Mad2 affects multiple cellular functions. In either event, the observation that proteins involved in regu-
